Jeani Delagardelle's Net Worth

$0

Estimate Recalculated Dec 3, 2025 08:04PM EST

Who is Jeani Delagardelle

Jeani Delagardelle does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include iRhythm Technologies, Inc., Oxford Immunotec Global PLC, MEI Pharma, Inc., Durata Therapeutics, Inc., Versartis, Inc., CHIMERIX INC, ICAGEN INC, Relypsa Inc, CONCERT PHARMACEUTICALS, INC., Transcept Pharmaceuticals Inc, and WORLD HEART CORP.

SEC CIK

Jeani Delagardelle's CIK is 0001441563

Past Insider Trading and Trends

2011 was Jeani Delagardelle's most active year for acquiring shares with 2 total transactions. Jeani Delagardelle's most active month to acquire stocks was the month of May. 2011 saw Jeani Delagardelle paying a total of $0.00 for 16,000 shares, this is the most they've acquired in one year.

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Relypsa Inc

Investor
Updated Nov 20, 2013
Form 4
16.19%
294.65K
$10.89
-$238.60K
Nov 20, 2013
2.11M
Purchase
Nov 20
Form 3
Nov 14, 2013
Showing 2 results

iRhythm Technologies, Inc.

Investor
Updated Oct 25, 2016
Form 4
69.38%
713.36K
$17.00
Oct 25, 2016
1.74M
Purchase
Oct 25
Form 3
Oct 19, 2016
Showing 2 results

Oxford Immunotec Global PLC

Investor
Updated Dec 03, 2013
Form 4
Dec 03, 2013
Form 3
Nov 21, 2013
1.38M
Showing 2 results

CONCERT PHARMACEUTICALS, INC.

Investor
Updated Feb 21, 2014
Form 4
612.04K
Feb 21, 2014
107.33K
Options
Feb 19
Form 3
Feb 12, 2014
15.29K
Showing 2 results

MEI Pharma, Inc.

Investor
Updated Mar 26, 2015
Form 4
-100.00%
-1.60M
$1.97
-$3.16M
Mar 26, 2015
Sale
Mar 24
Form 4
-4.71%
-79.08K
$6.01
-$475.58K
Dec 10, 2014
1.60M
Sale
Dec 08 - Dec 09
Form 4
-17.84%
-365.00K
$8.25
-$3.01M
Nov 25, 2013
1.68M
Sale
Nov 21
Form 4
-8.91%
-200.00K
$8.57
-$1.71M
May 08, 2013
2.05M
Sale
May 06 - May 08
Form 4
-10.28%
-257.30K
$8.48
-$2.18M
Apr 22, 2013
2.25M
Sale
Apr 18 - Apr 19
Form 4
-16.57%
-497.23K
$6.72
-$3.34M
Feb 20, 2013
2.50M
Sale
Feb 15 - Feb 19
Form 3
Dec 28, 2012
3.00M
Showing 7 results

Transcept Pharmaceuticals Inc

Investor
Updated Jul 20, 2011
Form 4
-17.17%
-245.06K
$4.47
-$1.10M
Jul 20, 2011
1.18M
Sale
Jul 18 - Jul 19
Form 4
-12.83%
-209.95K
$4.98
-$1.05M
Jul 15, 2011
1.43M
Sale
Jul 13 - Jul 14
Form 3
Feb 06, 2009
1.64M
Showing 3 results

Durata Therapeutics, Inc.

Investor
Updated Nov 18, 2014
Form 4
-100.00%
-3.03M
Nov 18, 2014
Disposition
Nov 17
Form 4
-83.13%
-14.92M
$9.00
Jul 26, 2012
3.03M
Buy-Options
Jul 24
Form 3
Jul 18, 2012
Showing 3 results

Versartis, Inc.

Investor
Updated Dec 22, 2014
Form 4
-5.86%
-150.00K
$19.01
-$2.85M
Dec 22, 2014
2.41M
Sale
Dec 18
Form 4
-23.81%
-800.00K
$19.37
-$15.50M
Nov 13, 2014
2.56M
Sale
Nov 11
Form 4
-0.37%
-12.56K
$20.02
-$251.33K
Oct 01, 2014
3.36M
Sale
Sep 29
Form 4
-91.32%
-35.47M
$21.02
Mar 28, 2014
3.37M
Buy-Options
Mar 27
Form 3
Mar 20, 2014
Showing 5 results

CHIMERIX INC

Investor
Updated Mar 20, 2014
Form 4
-31.20%
-700.00K
Mar 20, 2014
1.54M
Disposition
Mar 18
Form 3/A
Mar 20, 2014
Showing 2 results

ICAGEN INC

Investor
Updated Jul 29, 2011
Form 3
Jul 29, 2011
200.50K
Showing 1 results

WORLD HEART CORP

Investor
Updated Aug 06, 2012
Form 4
-100.00%
-8.41M
$0.10
-$233.02K
Aug 06, 2012
Disposition
Aug 02
Form 4/A
8.00K
Jul 01, 2011
8.00K
Grant
Jun 23
Form 4
8.00K
Jun 24, 2011
8.00K
Grant
Jun 23
Form 4
125.85%
4.68M
$2.13
$10.00M
Oct 21, 2010
8.41M
Purchase
Oct 19
Form 4
8.00K
Jun 10, 2010
8.00K
Grant
Jun 10
Form 4
31.30%
1.17M
$5.15
$6.00M
Jan 28, 2010
4.89M
Purchase
Jan 26
Form 4
8.00K
May 11, 2009
8.00K
Grant
May 07
Form 3
Aug 08, 2008
100.00M
Showing 8 results